AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Two physicians in a busy hallway

Physician burnout is down. Here’s what’s working—and what isn’t.

| 11 Min Read
Paper airplane in the shadow of a rocket

Why the future favors physician entrepreneurs

| 6 Min Read
Older adult speaks with physician

What age-friendly care means for older adults

| 8 Min Read
Doctor applies bandage to patient's arm following an immunization

What doctors want patients to know about flu vaccines

| 12 Min Read